Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLATINUM: Patiromer in ED Hyperkalemia
NCT04443608Phase 4Terminated
- Sponsor
- Comprehensive Research Associates
- Start
- Oct 2020
- Primary completion
- Mar 2023
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hyperkalemia comparing Veltassa + SOC with Placebo + SOC (2 arms). Primary endpoint: The need for additional potassium-lowering medical interventions at 6 hours. Started Oct 2020; status: terminated.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT04443608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443608.